2-Oxoindolin-thiazoline hybrids as scaffold-based therapeutics for T2DM-associated cognitive impairment: design, synthesis, in vitro and in silico studies
Year: 2025
Type: article
Abstract: ADME profiling indicated desirable pharmacokinetic properties, further supporting the therapeutic potential of these compounds as dual-action agents for the management of Alzheimer's disease and type 2 diabetes mellitus.
Source: RSC Medicinal Chemistry
DOI: 10.1039/d5md00628g
Institutions: Assiut University, Bezmiâlem Vakıf Üniversitesi, Bartin University
Language: English
Subfield: Organic Chemistry
Field: Chemistry
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W4416210350
